ReviewFrontiers in bioengineering and biotechnology2020

Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering.

Yanli Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.